StockData
Greenwich LifeSciences, Inc. logo

Greenwich LifeSciences, Inc. (GLSI) stock

GLSINasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 11, 2026Score 6/30
$18.70+4.94 (+35.90%)

Close on Nov 17, 2026Market cap $274.48MP/E –Yield –

Greenwich LifeSciences price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

No price to sales ratio figures for Greenwich LifeSciences

Greenwich LifeSciences has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Greenwich LifeSciences figures

See a number that looks wrong?